Photocure ASA ( (PHCUF) ) just unveiled an update.
Photocure ASA has announced the completion of a significant portion of its share buyback program, repurchasing 179,648 shares at an average price of NOK 57.57 per share. This strategic move, part of a broader initiative to repurchase up to 200,000 shares, is aimed at consolidating the company’s market position and potentially enhancing shareholder value. Following these transactions, Photocure now holds 1.08% of its own share capital, indicating a commitment to strengthening its financial standing and market influence.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in delivering transformative solutions for bladder cancer patients. Utilizing unique technology that makes cancer cells glow bright pink, Photocure aims to improve health outcomes for patients globally. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -18.87%
Average Trading Volume: 484
Technical Sentiment Signal: Strong Buy
Current Market Cap: $149.3M
See more data about PHCUF stock on TipRanks’ Stock Analysis page.